Report Cover

United States Functional Dyspepsia Drug Market Report & Forecast 2021-2027


United States Functional Dyspepsia Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units)
United States Functional Dyspepsia Drug Market Segment Percentages, By Type, 2020 (%)
    Prokinetic Drugs
    Gastric Antisecretory Drugs
    Others

United States Functional Dyspepsia Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units)
United States Functional Dyspepsia Drug Market Segment Percentages, By Application, 2020 (%)
    Hospitals
    Drugstores

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Functional Dyspepsia Drug revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Functional Dyspepsia Drug revenues share in United States market, 2020 (%)
Key companies Functional Dyspepsia Drug sales in United States market, 2016-2021 (Estimated), (M Units)
Key companies Functional Dyspepsia Drug sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Bayer
    Sumitomo
    Cadila Pharmaceuticals
    Teva
    Johnson & Johnson
    Pfizer
    Sanofi
    AstraZeneca
    Jiangsu Aosaikang Pharma
    Eisai
    Kyowa Kirin Pharmaceuticals
    Hanmi Pharm
1 Introduction to Research & Analysis Reports
    1.1 Functional Dyspepsia Drug Market Definition
    1.2 Market Segments
        1.2.1 Segment by Type
        1.2.2 Segment by Application
    1.3 United States Functional Dyspepsia Drug Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States Functional Dyspepsia Drug Overall Market Size
    2.1 United States Functional Dyspepsia Drug Market Size: 2021 VS 2027
    2.2 United States Functional Dyspepsia Drug Revenue, Prospects & Forecasts: 2016-2027
    2.3 United States Functional Dyspepsia Drug Sales: 2016-2027

3 Company Landscape
    3.1 Top Functional Dyspepsia Drug Players in United States Market
    3.2 Top United States Functional Dyspepsia Drug Companies Ranked by Revenue
    3.3 United States Functional Dyspepsia Drug Revenue by Companies
    3.4 United States Functional Dyspepsia Drug Sales by Companies
    3.5 United States Functional Dyspepsia Drug Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Functional Dyspepsia Drug Companies in United States Market, by Revenue in 2020
    3.7 Manufacturers Functional Dyspepsia Drug Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Functional Dyspepsia Drug Players in United States Market
        3.8.1 List of Tier 1 Functional Dyspepsia Drug Companies in United States
        3.8.2 List of Tier 2 and Tier 3 Functional Dyspepsia Drug Companies in United States

4 Sights by Type
    4.1 Overview
        4.1.1 By Type - United States Functional Dyspepsia Drug Market Size Markets, 2021 & 2027
        4.1.2 Prokinetic Drugs
        4.1.3 Gastric Antisecretory Drugs
        4.1.4 Others
    4.2 By Type - United States Functional Dyspepsia Drug Revenue & Forecasts
        4.2.1 By Type - United States Functional Dyspepsia Drug Revenue, 2016-2021
        4.2.2 By Type - United States Functional Dyspepsia Drug Revenue, 2022-2027
        4.2.3 By Type - United States Functional Dyspepsia Drug Revenue Market Share, 2016-2027
    4.3 By Type - United States Functional Dyspepsia Drug Sales & Forecasts
        4.3.1 By Type - United States Functional Dyspepsia Drug Sales, 2016-2021
        4.3.2 By Type - United States Functional Dyspepsia Drug Sales, 2022-2027
        4.3.3 By Type - United States Functional Dyspepsia Drug Sales Market Share, 2016-2027
    4.4 By Type - United States Functional Dyspepsia Drug Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States Functional Dyspepsia Drug Market Size, 2021 & 2027
        5.1.2 Hospitals
        5.1.3 Drugstores
    5.2 By Application - United States Functional Dyspepsia Drug Revenue & Forecasts
        5.2.1 By Application - United States Functional Dyspepsia Drug Revenue, 2016-2021
        5.2.2 By Application - United States Functional Dyspepsia Drug Revenue, 2022-2027
        5.2.3 By Application - United States Functional Dyspepsia Drug Revenue Market Share, 2016-2027
    5.3 By Application - United States Functional Dyspepsia Drug Sales & Forecasts
        5.3.1 By Application - United States Functional Dyspepsia Drug Sales, 2016-2021
        5.3.2 By Application - United States Functional Dyspepsia Drug Sales, 2022-2027
        5.3.3 By Application - United States Functional Dyspepsia Drug Sales Market Share, 2016-2027
    5.4 By Application - United States Functional Dyspepsia Drug Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
    6.1 Bayer
        6.1.1 Bayer Corporation Information
        6.1.2 Bayer Overview
        6.1.3 Bayer Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.1.4 Bayer Functional Dyspepsia Drug Product Description
        6.1.5 Bayer Recent Developments
    6.2 Sumitomo
        6.2.1 Sumitomo Corporation Information
        6.2.2 Sumitomo Overview
        6.2.3 Sumitomo Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.2.4 Sumitomo Functional Dyspepsia Drug Product Description
        6.2.5 Sumitomo Recent Developments
    6.3 Cadila Pharmaceuticals
        6.3.1 Cadila Pharmaceuticals Corporation Information
        6.3.2 Cadila Pharmaceuticals Overview
        6.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Description
        6.3.5 Cadila Pharmaceuticals Recent Developments
    6.4 Teva
        6.4.1 Teva Corporation Information
        6.4.2 Teva Overview
        6.4.3 Teva Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.4.4 Teva Functional Dyspepsia Drug Product Description
        6.4.5 Teva Recent Developments
    6.5 Johnson & Johnson
        6.5.1 Johnson & Johnson Corporation Information
        6.5.2 Johnson & Johnson Overview
        6.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.5.4 Johnson & Johnson Functional Dyspepsia Drug Product Description
        6.5.5 Johnson & Johnson Recent Developments
    6.6 Pfizer
        6.6.1 Pfizer Corporation Information
        6.6.2 Pfizer Overview
        6.6.3 Pfizer Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.6.4 Pfizer Functional Dyspepsia Drug Product Description
        6.6.5 Pfizer Recent Developments
    6.7 Sanofi
        6.7.1 Sanofi Corporation Information
        6.7.2 Sanofi Overview
        6.7.3 Sanofi Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.7.4 Sanofi Functional Dyspepsia Drug Product Description
        6.7.5 Sanofi Recent Developments
    6.8 AstraZeneca
        6.8.1 AstraZeneca Corporation Information
        6.8.2 AstraZeneca Overview
        6.8.3 AstraZeneca Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.8.4 AstraZeneca Functional Dyspepsia Drug Product Description
        6.8.5 AstraZeneca Recent Developments
    6.9 Jiangsu Aosaikang Pharma
        6.9.1 Jiangsu Aosaikang Pharma Corporation Information
        6.9.2 Jiangsu Aosaikang Pharma Overview
        6.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Description
        6.9.5 Jiangsu Aosaikang Pharma Recent Developments
    6.10 Eisai
        6.10.1 Eisai Corporation Information
        6.10.2 Eisai Overview
        6.10.3 Eisai Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.10.4 Eisai Functional Dyspepsia Drug Product Description
        6.10.5 Eisai Recent Developments
    6.11 Kyowa Kirin Pharmaceuticals
        6.11.1 Kyowa Kirin Pharmaceuticals Corporation Information
        6.11.2 Kyowa Kirin Pharmaceuticals Overview
        6.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Description
        6.11.5 Kyowa Kirin Pharmaceuticals Recent Developments
    6.12 Hanmi Pharm
        6.12.1 Hanmi Pharm Corporation Information
        6.12.2 Hanmi Pharm Overview
        6.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales and Revenue in United States Market (2016-2021)
        6.12.4 Hanmi Pharm Functional Dyspepsia Drug Product Description
        6.12.5 Hanmi Pharm Recent Developments

7 United States Functional Dyspepsia Drug Production Capacity, Analysis
    7.1 United States Functional Dyspepsia Drug Production Capacity, 2016-2027
    7.2 Functional Dyspepsia Drug Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
    8.1 Market Opportunities & Trends
    8.2 Market Drivers
    8.3 Market Restraints

9 Functional Dyspepsia Drug Supply Chain Analysis
    9.1 Functional Dyspepsia Drug Industry Value Chain
    9.2 Functional Dyspepsia Drug Upstream Market
    9.3 Functional Dyspepsia Drug Downstream and Clients
    9.4 Marketing Channels Analysis
        9.4.1 Marketing Channels
        9.4.2 Functional Dyspepsia Drug Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
    11.1 Note
    11.2 Examples of Clients
    11.3 Author Details
    11.4 Disclaimer

List of Tables Table 1. Key Players of Functional Dyspepsia Drug in United States Market Table 2. Top Functional Dyspepsia Drug Players in United States Market, Ranking by Revenue (2019) Table 3. United States Functional Dyspepsia Drug Revenue by Companies, (US$, Mn), 2016-2021 Table 4. United States Functional Dyspepsia Drug Revenue Share by Companies, 2016-2021 Table 5. United States Functional Dyspepsia Drug Sales by Companies, (M Units), 2016-2021 Table 6. United States Functional Dyspepsia Drug Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Functional Dyspepsia Drug Price (2016-2021) & (US$/Unit) Table 8. Manufacturers Functional Dyspepsia Drug Product Type Table 9. List of Tier 1 Functional Dyspepsia Drug Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Functional Dyspepsia Drug Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Prokinetic Drugs Table 12. Major Manufacturers of Gastric Antisecretory Drugs Table 13. By Type - United States Functional Dyspepsia Drug Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - United States Functional Dyspepsia Drug Revenue (US$, Mn), 2016-2021 Table 15. By Type - United States Functional Dyspepsia Drug Revenue (US$, Mn), 2022-2027 Table 16. By Type - United States Functional Dyspepsia Drug Sales (M Units), 2016-2021 Table 17. By Type - United States Functional Dyspepsia Drug Sales (M Units), 2022-2027 Table 18. By Application - United States Functional Dyspepsia Drug Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - United States Functional Dyspepsia Drug Revenue (US$, Mn), 2016-2021 Table 20. By Application - United States Functional Dyspepsia Drug Revenue (US$, Mn), 2022-2027 Table 21. By Application - United States Functional Dyspepsia Drug Sales (M Units), 2016-2021 Table 22. By Application - United States Functional Dyspepsia Drug Sales (M Units), 2022-2027 Table 23. Bayer Corporation Information Table 24. Bayer Description and Major Businesses Table 25. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 26. Bayer Functional Dyspepsia Drug Product Table 27. Bayer Recent Developments Table 28. Sumitomo Corporation Information Table 29. Sumitomo Description and Major Businesses Table 30. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 31. Sumitomo Functional Dyspepsia Drug Product Table 32. Sumitomo Recent Developments Table 33. Cadila Pharmaceuticals Corporation Information Table 34. Cadila Pharmaceuticals Description and Major Businesses Table 35. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 36. Cadila Pharmaceuticals Functional Dyspepsia Drug Product Table 37. Cadila Pharmaceuticals Recent Developments Table 38. Teva Corporation Information Table 39. Teva Description and Major Businesses Table 40. Teva Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 41. Teva Functional Dyspepsia Drug Product Table 42. Teva Recent Developments Table 43. Johnson & Johnson Corporation Information Table 44. Johnson & Johnson Description and Major Businesses Table 45. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 46. Johnson & Johnson Functional Dyspepsia Drug Product Table 47. Johnson & Johnson Recent Developments Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Major Businesses Table 50. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 51. Pfizer Functional Dyspepsia Drug Product Table 52. Pfizer Recent Developments Table 53. Sanofi Corporation Information Table 54. Sanofi Description and Major Businesses Table 55. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 56. Sanofi Functional Dyspepsia Drug Product Table 57. Sanofi Recent Developments Table 58. AstraZeneca Corporation Information Table 59. AstraZeneca Description and Major Businesses Table 60. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 61. AstraZeneca Functional Dyspepsia Drug Product Table 62. AstraZeneca Recent Developments Table 63. Jiangsu Aosaikang Pharma Corporation Information Table 64. Jiangsu Aosaikang Pharma Description and Major Businesses Table 65. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 66. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Table 67. Jiangsu Aosaikang Pharma Recent Developments Table 68. Eisai Corporation Information Table 69. Eisai Description and Major Businesses Table 70. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 71. Eisai Functional Dyspepsia Drug Product Table 72. Eisai Recent Developments Table 73. Kyowa Kirin Pharmaceuticals Corporation Information Table 74. Kyowa Kirin Pharmaceuticals Description and Major Businesses Table 75. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 76. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Table 77. Kyowa Kirin Pharmaceuticals Recent Developments Table 78. Hanmi Pharm Corporation Information Table 79. Hanmi Pharm Description and Major Businesses Table 80. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 81. Hanmi Pharm Functional Dyspepsia Drug Product Table 82. Hanmi Pharm Recent Developments Table 83. Functional Dyspepsia Drug Production Capacity (M Units) of Key Manufacturers in United States Market, 2019-2021 (M Units) Table 84. United States Functional Dyspepsia Drug Capacity Market Share of Key Manufacturers, 2019-2021 Table 85. Functional Dyspepsia Drug Market Opportunities & Trends in United States Market Table 86. Functional Dyspepsia Drug Market Drivers in United States Market Table 87. Functional Dyspepsia Drug Market Restraints in United States Market Table 88. Functional Dyspepsia Drug Raw Materials Table 89. Functional Dyspepsia Drug Raw Materials Suppliers in United States Market Table 90. Typical Functional Dyspepsia Drug Downstream Table 91. Functional Dyspepsia Drug Downstream Clients in United States Market Table 92. Functional Dyspepsia Drug Distributors and Sales Agents in United States Market List of Figures Figure 1. Functional Dyspepsia Drug Product Picture Figure 2. Functional Dyspepsia Drug Segment by Type Figure 3. Functional Dyspepsia Drug Segment by Application Figure 4. United States Functional Dyspepsia Drug Market Overview: 2020 Figure 5. United States Functional Dyspepsia Drug Market Size: 2021 VS 2027 (US$, Mn) Figure 6. United States Functional Dyspepsia Drug Revenue, 2016-2027 (US$, Mn) Figure 7. Functional Dyspepsia Drug Sales in United States Market: 2016-2027 (M Units) Figure 8. The Top 3 and 5 Players Market Share by Functional Dyspepsia Drug Revenue in 2020 Figure 9. Prokinetic Drugs Product Picture Figure 10. Gastric Antisecretory Drugs Product Picture Figure 11. Others Product Picture Figure 12. By Type - United States Functional Dyspepsia Drug Sales Market Share, 2016-2027 Figure 13. By Type - United States Functional Dyspepsia Drug Revenue Market Share, 2016-2027 Figure 14. By Type - United States Functional Dyspepsia Drug Price (US$/Unit), 2016-2027 Figure 15. Hospitals Figure 16. Drugstores Figure 17. By Application - United States Functional Dyspepsia Drug Sales Market Share, 2016-2027 Figure 18. By Application - United States Functional Dyspepsia Drug Revenue Market Share, 2016-2027 Figure 19. By Application - United States Functional Dyspepsia Drug Price (US$/Unit), 2016-2027 Figure 20. Bayer Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 21. Sumitomo Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. Cadila Pharmaceuticals Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. Teva Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. Johnson & Johnson Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. Pfizer Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. Sanofi Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. AstraZeneca Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 29. Eisai Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 30. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 31. Hanmi Pharm Functional Dyspepsia Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 32. United States Functional Dyspepsia Drug Production Capacity (M Units), 2016-2027 Figure 33. Functional Dyspepsia Drug Industry Value Chain Figure 34. Marketing Channels

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us